Reata Pharmaceuticals
Reata Pharmaceuticals, Inc. is a pharmaceutical company based in Plano, Texas. Founded in 2002, it is primarily focused on investigating experimental oral antioxidative and anti-inflammatory drugs, which dually activate the antioxidative transcription factor Nrf2 and inhibit the pro-inflammatory transcription factor NF-κB.
Basic Information
- Category: Rare Diseases
- Founded: 2002
- Headquarters: Plano, TX
- Website: reatapharma.com
Documented Facts
- Founded: 2002 (No linked source recorded for this statement.)
- CEO: of Reata Pharmaceuticals was J (No linked source recorded for this statement.)
Evidence and Sources
- Reata Pharmaceuticals — Official Site (official)
- Reata Pharmaceuticals on instagram (social)
- Reata Pharmaceuticals on facebook (social)
- Reata Pharmaceuticals on linkedin (social)
- Reata Pharmaceuticals — Wikipedia (reference)
Citation Guidance
Explore Rare Diseases profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Reata Pharmaceuticals.
- Canonical profile: https://brandsource.ai/brands/reata-pharmaceuticals
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/reata-pharmaceuticals/json-ld
- Citation profile API: https://brandsource.ai/api/brands/reata-pharmaceuticals/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (88/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2025-10-27T08:35:04.088Z
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Reata Pharmaceuticals, Inc. is a pharmaceutical company based in Plano, Texas. Founded in 2002, it is primarily focused on investigating experimental oral antioxidative and anti-inflammatory drugs, which dually activate the antioxidative transcription factor Nrf2 and inhibit the pro-inflammatory transcription factor NF-κB.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 4 supporting sources linked.
- 2 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.